Suitability of teriparatide and level of acceptance of pharmacotherapeutic recommendations in a healthcare management areaSuitability of teriparatide and level of acceptance of pharmacotherapeutic recommendations in a healthcare management area DOI: 10.7399/fh.2016.40.4.9953

• Main Authors: Maria Rosa Cantudo-Cuenca, Maria Isabel Guzmán Ramos, Maria Dolores Cantudo Cuenca, Mercedes Manzano García, Maria del Carmen Saborido Cansino, Ana Sánchez Pedrosa
• Format: Article
• Language: English
• Published: Grupo Aula Médica 2016-07-01
• Series: Farmacia Hospitalaria
• Subjects: Suitability; Teriparatide; ; Recommendation
• Online Access: http://www.aulamedica.es/fh/pdf/9953.pdf
• ISSN: 1130-6343; 2171-8695

Objective: To analyse the suitability of teriparatide prescriptions for osteoporosis treatment in a health management area, as well as the level of acceptance of pharmacotherapeutic recommendations made to physicians. Design: A prospective interventional study conducted from february 2015 to june 2015. Setting: South Seville Health Management Area. Participants: Patients receiving teriparatide. Main measurements: Suitability of teriparatide prescriptions according to Clinical Practice Guidelines and level of acceptance of pharmacotherapeutic recommendations. Results: Teriparatide prescriptions were unsuitable in 45 patients (68.2%); 11 due to no indication, 17 patients did not have previous treatments with first-line drugs, 6 due to contraindications and 9 patients were treated for more than 24 months with the drug. Besides, 4 prescriptions were unsuitable because of combination with other therapies. The acceptance of pharmacotherapeutic recommendations was 64.4%, leading to teriparatide discontinuation in 21 patients (72.4%), and a switch to alendronate or ibandronate in another 8 patients. Conclusions: A high percentage of teriparatide prescriptions is unsuitable in our health care management area, but it has decreased after pharmacist intervention.